Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL-HD: Patiromer for Hyperkalemia in Hemodialysis
NCT03781089Phase 4Completed
- Sponsor
- Duke University
- Start
- Jun 2019
- Primary completion
- Mar 2023
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of patiromer in hyperkalemia, sponsored by Duke University. Started Jun 2019; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT03781089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781089.